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 2
Acinetobacter baumannii pigmented strains are not common in clinical settings. 40 
In the present work we report an outbreak caused by indigo-pigmented A. 41 
baumannii strains isolated in an acute hospital in Argentina from March to 42 
September 2012. Pan-PCR assays exposed a unique pattern belonging to the 43 
recently described regional CC113B/CC79P that confirms the relevant 44 
relationships among the indigo-pigmented A. baumannii strains. All of them were 45 
extensively drug-resistant and harbored different genetic elements associated 46 
with horizontal genetic transfer as the transposon Tn2006, class 2 integrons, 47 
AbaR-type islands, IS125, IS26, strA, strB, florR and the small recombinase 48 
ISCR2 associated to the sul2 gene proceed by ISAba1.  49 
 50 
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INTRODUCTION 52 
Acinetobacter baumannii is a well-known significant nosocomial pathogen that 53 
causes a variety of diseases (1-3). The ability of this bacterium to survive for long 54 
periods on inanimate surfaces and its extensively drug resistance makes A. 55 
baumannii a successful microorganism able to cause outbreaks (4, 5). Many 56 
outbreaks due to A. baumannii have been documented in the literature (6-10). 57 
However, no outbreaks due to indigo-pigmented A. baumannii strains have been 58 
documented yet. 59 
The production of indigo pigment in the genus Acinetobacter was only previously 60 
reported in the environmental Acinetobacter sp. ST-550 and in the A. baumannii 61 
ATCC 19606 strains in the presence of indole as a carbon source (11-13). This 62 
production may be attributed to the activity of a monooxygenase or dioxygenase 63 
enzyme (11, 12). In the present work we report the molecular characterization of 64 
an outbreak of indigo-pigmented A. baumannii strains that began in the 65 
traumatology service of an acute hospital in Argentina.  66 
67 
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 4
MATERIALS 68 
Bacterial strains. A total of thirteen pigmented A. baumannii strains were 69 
isolated in the traumatology service (n=7), coronary care unit (n=2), plastic 70 
surgery unit (n=2), and intensive care unit (n=2) of an acute Hospital from 71 
Argentina from March to September 2012 (Table 1). The strains were identified 72 
at the species level by using several criteria: a) analyzed on a VITEK 2 Compact 73 
(bioMérieux) ; b) amplified ribosomal DNA restriction analysis (ARDRA) using the 74 
primers 5’TGGCTCAGATTGAACGCTGGCGGC and 75 
5’TACCTTGTTACGACTTCACCCCA with the following cycling conditions: initial 76 
denaturation at 95°C for 5 min, the reaction was run through 35 cycles of 77 
denaturation at 95°C for 30 s, annealing at 50°C for 45 s, and extension at 72°C 78 
for 1 min (14); c) amplification and sequencing of the 16S rRNA with the primers 79 
fD2 5’AGAGTTTGATCATGGCTCAG and Rp2 5’ACGGCTACCTTGTTACGACTT 80 
described by Weisburg et al. (15), using 35 cycles of denaturation at 95°C for 30 81 
s, annealing at 52°C for 30 s, and extension at 72°C for 1 min as cycling 82 
conditions; and d) amplification and sequencing of the ropB gene using the 83 
primers Vic4 5’GGCGAAATGGC(AGT)GA(AG)AACCA and Vic6 84 
GA(AG)TC(CT)TCGAAGTTGTAACC the same cycling conditions as described 85 
in c (http:// www.pasteur.fr/recherche/genopole/PF8/mlst/Abaumannii.html). 86 
Antibiotic susceptibility tests were performed using the VITEK 2 System that uses 87 
the panel AST-082 (GNS susceptibility card). The MIC results were interpreted 88 
according to CLSI categories (16). 89 
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 5
DNA techniques. Total DNA was extracted with Master Pure DNA purification 90 
kit, following the manufacturer’s instructions (Epicentre, Madison, WI, USA). To 91 
determine the presence of the most prevalent OXA carbapenemase genes in our 92 
region (17), such as blaOXA-23-like and blaOXA-58-like, PCR reactions were carried out 93 
using the primers and cycling as described in the literature (17). For the blaOXA 94 
amplification reactions the strains AB3 (blaOXA-23-like) and Ab1 (blaOXA-58-like) were 95 
used as positive controls (17). The presence of insertion sequences (ISAba1, 96 
ISAba3, IS125, IS26, IS825, ISCR1, and ISCR2), class 1 and class 2 integrons, 97 
and the corresponding variable regions of integrons were determined using 98 
specific primers as previously described (17-20). To further characterize the 99 
strains, the occurrence of AbaR islands using the previously described specific 100 
primers (4F, 4R, 2F, 2R) was performed (21, 22). We also searched for the 101 
presence of tetracycline resistant genes using specific primers to amplify tet(B), 102 
tet(A), tet(M), tet(39) and tet(H) genes under the conditions described in the 103 
literature (21, 22). The amplification of the iacA gene (iacAF 104 
5’ATGAATAAGTTGTCTAAAATGGAG and iacAR 105 
5’GCAAAACAACACGCGTAATG), involved in indigo production, was carried out 106 
using as positive control the A. baumannii strains 19606 and ATCC 17978. 107 
In addition, the relatedness of strains was determined using two different 108 
molecular typing techniques, the OD-PCR and the recently described Pan-PCR 109 
assay, which consist of a multiplex PCR of 6 genes allowing the identification of 110 
relevant relationships among strains (23, 24).  To carry out the OD PCR the 111 
primer 19 5’ GGTCGACYTTNGYNGGRTC was employed, using a low-112 
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 6
stringency amplification protocol (5 min denaturation at 95 °C, 40 cycles in 1 min 113 
at 93°C, 1.5 min at 36 °C, 2 min at 72 °C, followed by 10 min at 72 °C) (23, 24).  114 
The Pan-PCR assay was performed as described by Yang et al. 2013 using the 115 
6 designed pairs of primers that allow to amplify a group of genes whose variable 116 
presence is able to identify the strains of interest (23, 24). The cycling conditions 117 
employed for the reaction were an initial denaturation at 95°C for 5 min, followed 118 
by 20 cycles of denaturation (95°C for 30 s), annealing (60°C for 30 s), and 119 
extension (72°C for 1 min 30 s) and a single final extension at 72°C for 10 min. 120 
 Sequence analysis. Sequencing was performed on both DNA strands using an 121 
ABIPrism 3100 BioAnalyzer and Taq FS Terminator Chemistry (Taq FS, Perkin-122 
Elmer). Sequences were examined and assembled with Sequencher 4.7 123 
software (Gene Codes Corp.) and BLAST (version 2.0) software 124 
(http://www.ncbi.nlm.nih.gov/BLAST/). 125 
126 
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 7
RESULTS  127 
All strain were identify as A. baumannii using several methods: a) the bionumber 128 
obtained by VITEK compact was 0201010303500352, giving an identification of 129 
A. baumannii complex with 99 % probability; b) the ARDRA profile obtained was 130 
11123 which is characteristic for A. baumannii; c) the sequence analysis of the 131 
16S rRNA gene (Accession number: KF410895) revealed 99% of identity with 132 
the sequences corresponding to the 16S rRNA gene of A. baumannii (Accession 133 
number CP003846), d) the sequence of the rpoB gene (Accession number 134 
KF410896) was 100 % identical to the rpoB gene of A. baumannii (Accession 135 
number DQ207471).   136 
Although two antibiotic resistance profiles among the 13 indigo-pigmented A. 137 
baumannii strains were identified (Table I), all strains were categorized as 138 
extensively drug-resistant (XDR) according to the recent definitions suggested by 139 
Magiorakos et al, 2012 (25).  140 
The clinical outcome of patients involved in the outbreak showed five deaths. 141 
However, the association between A. baumannii colonization or infection and 142 
mortality could not be established because patients were compromised or with 143 
underlying diseases. 144 
The indigo-pigmented strains showed a unique pattern by OD-PCR that clustered 145 
all of them in a single clone (Figure 1a). Furthermore, we decided to perform the 146 
new recently described pan-PCR assay, which demonstrated to be able to 147 
distinguish among strains with identical MLST (24). This technique showed a 148 
unique amplification pattern, with exception of one strain (33405) in which one 149 
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 8
band is missing, confirming the relevant relationships among the indigo-150 
pigmented A. baumannii strains (Figure 1b). As this technique is defined as a 151 
highly discriminatory PCR assay, we consider that in this particular strain 152 
(33405), the pan-PCR assay is showing a distinct variation in the gene content of 153 
this strain. 154 
Also, the use of pan-PCR allowed us to identify that the indigo-pigmented A. 155 
baumannii strains possessed the same amplification pattern as the one obtained 156 
in the control strain for the CC113B/CC79P clonal complex, which was shown to 157 
be prevalent in clinical A. baumannii isolates from our country (26) (Figure 1b). 158 
This particular clonal complex, that differ from the International clones I, II and III, 159 
was also described in A. baumannii isolates from Brazil and Spain (26-28).  160 
The dates when the A. baumannii strains were recovered clearly showed that the 161 
outbreak began in the traumatology service and then spread to other services 162 
(Table 1). Attempts to recover A. baumannii strains from environmental sources 163 
other than the patients hospitalized yielded no indigo-pigmented A. baumannii 164 
strains. An XDR non-pigmented A. baumannii strain (A179) was recovered from 165 
the wound-healing box used in the traumatology service. 166 
The molecular characterization of the outbreak was carried out by PCR reactions 167 
and sequence analyses were performed to identify the presence of antibiotic 168 
resistant genes and genetic elements associated with antibiotic resistance. The 169 
iacA gene was also searched giving positive results in all the indigo-pigmented A. 170 
baumannii strains and also in the XDR non-pigmented A. baumannii strain A179. 171 
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 9
While all the strains harbored the Tn2006 transposon, which carries blaOXA-23, the 172 
amplification of blaOXA-58 and blaOXA-143 carbapenemase genes gave negative 173 
results. All indigo-pigmented strains possessed the IS125, IS26, strA, strB, and 174 
florR genes. Class 2 integrons were also found in all the indigo-pigmented A. 175 
baumannii strains, whereas no class 1 integrons were found. This result is in 176 
accordance with our previous studies, which showed that class 2 integrons are 177 
more abundant than class 1 integrons in A. baumannii strains from Argentina (20, 178 
29, 30). PCR cartography and sequence analysis exposed that In2-7, which is 179 
the common class 2 integron array, was present in the 13 strains studied (20, 180 
29).  181 
In addition, all indigo-pigmented strains were positive for the presence, not only 182 
for AbaR-type genomic islands, but also for a cluster containing ISAba1-sul2-183 
ISCR2.  184 
Previously, the A. baumannii A297 strain harboring a similar cluster, which 185 
contains ISAba1-sul2-ISCR2-strB-strA genes, has been described (19). 186 
However, no positive result to link the strB and strA genes with ISCR2 were 187 
obtained in our A. baumannii indigo-pigmented strains. 188 
The PCR reactions to amplify tetracycline resistant determinants, such as tet(A) 189 
and tet(B) gave negative results. In addition, no evidences of aadB, aac(6’)-Ib 190 
and aphA1 genes were found.  191 
Our first thoughts were that the A179 strain, which was found in a wound-healing 192 
box of the traumatology service, maybe the source of the described outbreak 193 
and/or the source of the antimicrobial resistant mechanisms found in the indigo-194 
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 10
pigmented strains. To confirm our hypothesis the characterization of A179 was 195 
carried out. 196 
The non-pigmented A. baumannii A179 strain was only susceptible to 197 
minocycline, tigecycline, amikacin and colistin. The same profile was described in 198 
nine of the indigo-pigmented strains (Table I). As we found in the indigo-199 
pigmented strains, A179 harbored Tn2006 and AbaR-type genomic island. The 200 
clonal relationship carried out by OD-PCR and Pan-PCR showed that A179 201 
belongs to a different clone (Figure 1a and 1b). Also, when we compared this 202 
strain with the indigo-pigmented strains we found some differences in the content 203 
of the genetic determinants analyzed in the present work. Instead of class 2 204 
integrons we found a class 1 integron, which carries the array aacC1-orfP-orfQ-205 
aadA1. This integron was previously described not only in the wide spread 206 
international clone 1, but also in Argentinean isolates (30, 31). As we found in the 207 
indigo-pigmented strains, A179 harbors Tn2006 and AbaR-type genomic island. 208 
However, no evidences of ISAba125, ISCR2, strA, strB and floR genes were 209 
detected.  210 
DISCUSSION 211 
To our knowledge, this is the first report of an outbreak of XDR indigo-pigmented 212 
A. baumannii strains. The molecular characterization of the strains clearly 213 
exposed the wide number on genetic elements present in these strains, thus 214 
supporting the general idea that A. baumannii has a particular ability to acquire 215 
different genetic elements to evolve rapidly to the XDR and PDR.  216 
In all the strains, we observed the presence not only of ISAbaI and ISAba125, 217 
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 11
which are the most prevalent ISs in this microorganism, but also of IS26 and the 218 
ISCR2 element. Our findings are in agreement with the conception that insertion 219 
sequences have a predominant role in the acquisition and dissemination of 220 
antibiotic resistance within A. baumannii. The virulence associated to indigo-221 
pigmented isolates remains to be established. 222 
Our study also highlights the importance of rigorous infection prevention and 223 
control measures to control an outbreak of A. baumannii. Once the organism is 224 
identified, universal hygiene measures should be observed to avoid further 225 
spread and outbreaks. 226 
 227 
ACKNOWLEDGMENTS 228 
M.S.R. and D.C. are career investigators of CONICET, Argentina. E.V. has 229 
doctoral fellowships from CONICET.  230 
Conflict of interest statement 231 
None declared. 232 
Funding sources 233 
This study was supported by grant PIP 11420100100152 to M.S.R. and grant 234 
UBACyTs to M.S.R. and D.C, Buenos Aires, Argentina.235 
 o
n
 N
ovem
ber 24, 2016 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 12
REFERENCES  236 
1. Roca I, Espinal P, Vila-Farres X, Vila J. 2012. The Acinetobacter baumannii 237 
Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant 238 
Menace. Front Microbiol 3:148. 239 
2. Visca P, Seifert H, Towner KJ. 2011. Acinetobacter infection--an emerging 240 
threat to human health. IUBMB Life 63:1048-1054. 241 
3. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, 242 
Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 243 
2012. The success of acinetobacter species; genetic, metabolic and virulence 244 
attributes. PLoS One 7:e46984. 245 
4. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: 246 
emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. 247 
5. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of 248 
Acinetobacter baumannii on dry surfaces: comparison of outbreak and 249 
sporadic isolates. J Clin Microbiol 36:1938-1941. 250 
6. Zarrilli R, Di Popolo A, Bagattini M, Giannouli M, Martino D, Barchitta M, 251 
Quattrocchi A, Iula VD, de Luca C, Scarcella A, Triassi M, Agodi A. 2012. 252 
Clonal spread and patient risk factors for acquisition of extensively drug-253 
resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J 254 
Hosp Infect 82:260-265. 255 
7. Chmielarczyk A, Higgins PG, Wojkowska-Mach J, Synowiec E, Zander E, 256 
Romaniszyn D, Gosiewski T, Seifert H, Heczko P, Bulanda M. 2012. 257 
Control of an outbreak of Acinetobacter baumannii infections using 258 
vaporized hydrogen peroxide. J Hosp Infect 81:239-245. 259 
8. Domenech de Celles M, Salomon J, Marinier A, Lawrence C, Gaillard JL, 260 
Herrmann JL, Guillemot D. 2012. Identifying more epidemic clones during a 261 
hospital outbreak of multidrug-resistant Acinetobacter baumannii. PLoS One 262 
7:e45758. 263 
9. Goic-Barisic I, Towner KJ, Kovacic A, Sisko-Kraljevic K, Tonkic M, Novak 264 
A, Punda-Polic V. 2011. Outbreak in Croatia caused by a new carbapenem-265 
resistant clone of Acinetobacter baumannii producing OXA-72 266 
carbapenemase. J Hosp Infect 77:368-369. 267 
10. Ansaldi F, Canepa P, Bassetti M, Zancolli M, Molinari MP, Talamini A, 268 
Ginocchio F, Durando P, Mussap M, Orengo G, Viscoli C, Icardi G. 2011. 269 
Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in 270 
intensive care units of a tertiary referral hospital in Italy: combined 271 
molecular approach for epidemiological investigation. J Hosp Infect 79:134-272 
140. 273 
11. Doukyu N, Toyoda K, Aono R. 2003. Indigo production by Escherichia coli 274 
carrying the phenol hydroxylase gene from Acinetobacter sp strain ST-550 in 275 
a water-organic solvent two-phase system. Appl Microbiol Biotechnol 276 
60:720-725. 277 
12. Doukyu N, Nakano T, Okuyama Y, Aono R. 2002. Isolation of an 278 
Acinetobacter sp. ST-550 which produces a high level of indigo in a water-279 
 o
n
 N
ovem
ber 24, 2016 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 13
organic solvent two-phase system containing high levels of indole. Appl 280 
Microbiol Biotechnol 58:543-546. 281 
13. Lin GH, Chen HP, Huang JH, Liu TT, Lin TK, Wang SJ, Tseng CH, Shu HY. 282 
2012. Identification and characterization of an indigo-producing oxygenase 283 
involved in indole 3-acetic acid utilization by Acinetobacter baumannii. 284 
Antonie Van Leeuwenhoek 101:881-890. 285 
14. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, 286 
Claeys G, Verschraegen G. 1995. Identification of Acinetobacter genomic 287 
species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 288 
33:11-15. 289 
15. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 1991. 16S ribosomal DNA 290 
amplification for phylogenetic study. J Bacteriol 173:697-703. 291 
16. CLSI. 2011. Performance standards for antimicrobial susceptibility testing; 292 
twenty-first informational supplement CLSI document M100-S21. Clinical 293 
and Laboratory Standards Institute, Wayne (PA) Manual CLSI 2011. 294 
17. Merkier AK, Catalano M, Ramirez MS, Quiroga C, Orman B, Ratier L, 295 
Famiglietti A, Vay C, Di Martino A, Kaufman S, Centron D. 2008. 296 
Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter 297 
baumannii isolates from Argentina. J Infect Dev Ctries 2:235-240. 298 
18. Orman BE, Pineiro SA, Arduino S, Galas M, Melano R, Caffer MI, Sordelli 299 
DO, Centron D. 2002. Evolution of multiresistance in nontyphoid salmonella 300 
serovars from 1984 to 1998 in Argentina. Antimicrob Agents Chemother 301 
46:3963-3970. 302 
19. Nigro SJ, Post V, Hall RM. 2011. The multiresistant Acinetobacter baumannii 303 
European clone I type strain RUH875 (A297) carries a genomic antibiotic 304 
resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-305 
sul2-CR2-strB-strA. J Antimicrob Chemother 66:1928-1930. 306 
20. Ramirez MS, Pineiro S, Centron D. 2010. Novel insights about class 2 307 
integrons from experimental and genomic epidemiology. Antimicrob Agents 308 
Chemother 54:699-706. 309 
21. Vilacoba E, Almuzara M, Gulone L, Traglia GM, Figueroa SA, Sly G, 310 
Fernandez A, Centron D, Ramirez MS. 2012. Emergence and spread of 311 
tet(B)::ISCR2 plasmid-borne in minocycline resistance Acinetobacter 312 
baumannii isolates. Antimicrob Agents Chemother. 313 
22. Shaikh F, Spence RP, Levi K, Ou HY, Deng Z, Towner KJ, Rajakumar K. 314 
2009. ATPase genes of diverse multidrug-resistant Acinetobacter baumannii 315 
isolates frequently harbour integrated DNA. J Antimicrob Chemother 63:260-316 
264. 317 
23. Limansky AS, Viale AM. 2002. Can composition and structural features of 318 
oligonucleotides contribute to their wide-scale applicability as random PCR 319 
primers in mapping bacterial genome diversity? J Microbiol Methods 50:291-320 
297. 321 
24. Yang JY, Brooks S, Meyer JA, Blakesley RR, Zelazny AM, Segre JA, Snitkin 322 
ES. 2013. Pan-PCR, a computational method for designing bacterium-typing 323 
assays based on whole-genome sequence data. Journal of clinical 324 
microbiology 51:752-758. 325 
 o
n
 N
ovem
ber 24, 2016 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 14
25. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, 326 
Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, 327 
Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 328 
2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant 329 
bacteria: an international expert proposal for interim standard definitions 330 
for acquired resistance. Clin Microbiol Infect 18:268-281. 331 
26. Stietz MS, Ramirez MS, Vilacoba E, Merkier AK, Limansky AS, Centron D, 332 
Catalano M. 2013. Acinetobacter baumannii extensively drug resistant 333 
lineages in Buenos Aires hospitals differ from the international clones I-III. 334 
Infect Genet Evol 14:294-301. 335 
27. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef AP, Asensi 336 
MD, Peixe L. 2011. OXA-23-producing Acinetobacter baumannii: a new 337 
hotspot of diversity in Rio de Janeiro? J Antimicrob Chemother 66:62-65. 338 
28. Villalon P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez-Nieto 339 
JA. 2011. Clonal diversity of nosocomial epidemic Acinetobacter baumannii 340 
strains isolated in Spain. J Clin Microbiol 49:875-882. 341 
29. Ramirez MS, Morales A, Vilacoba E, Marquez C, Centron D. 2012. Class 2 342 
integrons dissemination among multidrug resistance (MDR) clones of 343 
Acinetobacter baumannii. Curr Microbiol 64:290-293. 344 
30. Ramirez MS, Stietz MS, Vilacoba E, Jeric P, Limansky AS, Catalano M, 345 
Centron D. 2011. Increasing frequency of class 1 and 2 integrons in 346 
multidrug-resistant clones of Acinetobacter baumannii reveals the need for 347 
continuous molecular surveillance. Int J Antimicrob Agents 37:175-177. 348 
31. D'Arezzo S, Capone A, Petrosillo N, Visca P, Ballardini M, Bartolini S, 349 
Bordi E, Di Stefano A, Galie M, Minniti R, Meledandri M, Pacciani L, 350 
Parisi G, Prignano G, Santini C, Valmarin M, Venditti M, Ziantoni S. 2009. 351 
Epidemic multidrug-resistant Acinetobacter baumannii related to European 352 
clonal types I and II in Rome (Italy). Clin Microbiol Infect 15:347-357. 353 
 354 
 355 
356 
 o
n
 N
ovem
ber 24, 2016 by guest
http://jcm.asm.org/
D
ow
nloaded from
 
 15
 357 
Legend for Figure 1 358 
Molecular typing of A. baumannii isolates. a) Ethidium bromide-stained 1.5% 359 
agarose gel electrophoresis showing OD-PCR patterns obtained in the A. 360 
baumannii strains. Numbers at the top of each lane correspond to strain 361 
numbers. Lane 15 corresponded to 1 kb ladder (O'GeneRuler 1 kb Plus DNA 362 
Ladder Fermentas) b) Ethidium bromide-stained 1 % agarose gel electrophoresis 363 
showing Pan-PCR amplification patterns obtained in the A. baumannii strains. 364 
Numbers at the top of each lane correspond to strain numbers. Lanes 2 and 3 365 
corresponded to control strains of CC109B/CC1P and CC113P/CC79P, 366 
respectively. Lane 17 corresponded to 1 kb ladder (O'GeneRuler 1 kb Plus DNA 367 
Ladder Fermentas). The XDR non-pigmented A. baumannii strain (A179), 368 
recovered from the wound-healing box used in the traumatology service, was 369 
also added in both assays. 370 
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Table 1. Indigo-pigmented A. baumannii strains characteristics and patient´s associated clinical condition. 371 
 372 
Strain Isolation 
date  
Patients 
age/ sex 
Underlying 
Disease 
Diagnosis at 
admission 
Nosocomial 
diagnostic 
Service Source Antibiotic resistance profile 
66 3/28/2012 47/Fa - ND Ab surgical 
site infection
TS Surgery’s 
wound 
TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
M30393 6/25/2012 55/Mb DBT Diabetic foot 
infection 
Ab surgical 
site infection
TS SSTI TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
M30121 6/19/2012 31/F NUD 
 
Pyomyositis Ab surgical 
site infection
TS SSTI TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
167 6/25/2012 65/M DBT Diabetic foot 
infection 
Ab surgical 
site infection
TS SSTI TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
192 7/17/2012 64/M DBT; CRF Prosthesis 
infection 
Ab surgical 
site infection
TS Mini-BAL TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
186 7/12/2012 56/M - Diabetic foot 
infection 
Ab surgical 
site infection
TS SSTI TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
M32757 8/15/2012 64/M DBT; CRF Prosthesis 
infection 
Ab surgical 
site infection
TS SSTI TMP, CAZ, FEP, CIP, PIP-TZ, IMI, MEM, 
GEN 
M32467 8/8/2012 Unkown/F NUD 
 
Burn 
infection 
Ab surgical 
site infection
PSU SSTI TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
M32469 8/8/2012 Unkown/F NUD 
 
Burn 
infection 
Ab surgical 
site infection
PSU SSTI TMP, CAZ, FEP, CIP, PIP-TZ, IMP, MEM, 
GEN 
M33405 8/28/2012 65/M - Scheduled 
CABG 
Ab surgical 
site infection
CCU Mini-BAL TMP, CAZ, FEP, CIP, PIP-TZ, IMP, MEM, 
GEN 
M33614 9/3/2012 45/M - Hemorrhagic 
stroke 
Ab VAP ICU Mini-BAL TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
M34050 9/10/2012 60/M - Hemorrhagic 
stroke 
Ab VAP ICU Tracheal 
aspirate 
TMP, AMK, CAZ, FEP, CIP, PIP-TZ, IMP, 
MEM, GEN 
F33943 9/7/2012 82/F - Respiratory 
failure, CAP 
Ab VAP CCU Mini-BAL TMP, CAZ, FEP, CIP, PIP-TZ, IMP, MEM, 
GEN 
F, female; M, male; DBT, diabetes; NUD, non-underlying disease; CRF, chronic renal failure; ND, not determined; CAP, community-373 
acquired pneumonia; Ab, Acinetobacter baumannii; VAP, ventilator-associated pneumonia, TS, traumatology service; PSU, plastic 374 
surgery unit; CCU, coronary care unit; ICU, intensive care unit; SSTI, skin and soft tissue infection; TMP, trimethoprim-375 
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sulfamethoxazole; AMK, amikacin; CAZ, ceftazidime; FEP, cefepime; CIP, ciprofloxacin PIP-TZ, piperacillin-tazobactam; IPM, 376 
imipenem; MEM, meropenem; GEN, gentamicin. 377 
  378 
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